Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NATALIZUMAB Cause White blood cell count increased? 211 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 211 reports of White blood cell count increased have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.3% of all adverse event reports for NATALIZUMAB.

211
Reports of White blood cell count increased with NATALIZUMAB
0.3%
of all NATALIZUMAB reports
6
Deaths
80
Hospitalizations

How Dangerous Is White blood cell count increased From NATALIZUMAB?

Of the 211 reports, 6 (2.8%) resulted in death, 80 (37.9%) required hospitalization, and 2 (0.9%) were considered life-threatening.

Is White blood cell count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 211 reports have been filed with the FAERS database.

What Other Side Effects Does NATALIZUMAB Cause?

Multiple sclerosis relapse (6,478) Fatigue (4,456) Multiple sclerosis (4,078) Memory impairment (3,024) Malaise (2,523) Fall (2,481) Headache (2,476) Gait disturbance (2,427) Prescribed underdose (2,162) Maternal exposure during pregnancy (1,948)

What Other Drugs Cause White blood cell count increased?

CLOZAPINE (2,988) ADALIMUMAB (1,710) RUXOLITINIB (1,529) IBRUTINIB (1,390) RITUXIMAB (886) METHOTREXATE (741) PREDNISONE (716) ETANERCEPT (615) IMATINIB (520) TOCILIZUMAB (478)

Which NATALIZUMAB Alternatives Have Lower White blood cell count increased Risk?

NATALIZUMAB vs NATALIZUMAB-SZTN NATALIZUMAB vs NATAMYCIN NATALIZUMAB vs NATEGLINIDE NATALIZUMAB vs NAVITOCLAX NATALIZUMAB vs NAXITAMAB-GQGK

Related Pages

NATALIZUMAB Full Profile All White blood cell count increased Reports All Drugs Causing White blood cell count increased NATALIZUMAB Demographics